| Literature DB >> 17107807 |
Fredrik Thorstensson1, Fredrik Wångsell, Ingemar Kvarnström, Lotta Vrang, Elizabeth Hamelink, Katarina Jansson, Anders Hallberg, Sa Rosenquist, Bertil Samuelsson.
Abstract
Potent tetrapeptidic inhibitors of the HCV NS3 protease have been developed incorporating 4-hydroxy-cyclopent-2-ene-1,2-dicarboxylic acid as a new N-acyl-l-hydroxyproline mimic. The hydroxycyclopentene template was synthesized in eight steps from commercially available (syn)-tetrahydrophthalic anhydride. Three different amino acids were explored in the P1-position and in the P2-position the hydroxyl group of the cyclopentene template was substituted with 7-methoxy-2-phenyl-quinolin-4-ol. The P3/P4-positions were then optimized from a set of six amino acid derivatives. All inhibitors were evaluated in an in vitro assay using the full-length NS3 protease. Several potent inhibitors were identified, the most promising exhibiting a K(i) value of 1.1nM.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17107807 DOI: 10.1016/j.bmc.2006.10.044
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641